Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients

被引：1
|
作者：
Morales-Orue, Ignacio [1 ,2 ,3 ]
Zafra-Martin, Juan [3 ]
Garcia, Laura [3 ]
Chicas-Sett, Rodolfo [3 ]
Castilla-Martinez, Juan [3 ]
Auxiliadora Cabezon, Maria [3 ]
Burgos, Javier [4 ]
Lloret, Marta [3 ]
Lara, Pedro C. [4 ,5 ]
机构：
[1] Punta Europa Hosp, Dept Radiat Oncol, Carretera Getares S-N, Algeciras 11207, Spain
[2] Punta Europa Hosp, Dept Med Oncol, Algeciras, Spain
[3] Dr Negrin Univ Hosp Gran Canaria, Dept Radiat Oncol, Las Palmas Gran Canaria, Spain
[4] San Roque Univ Hosp, Dept Oncol, Las Palmas Gran Canaria, Spain
[5] Fernando Pessoa Canarias Univ, Fac Hlth Sci, Las Palmas Gran Canaria, Spain
来源：
TRANSLATIONAL CANCER RESEARCH | 2020年 / 9卷
关键词：
Stereotactic ablative radiotherapy (SABR); elderly; oligometastatic; radiotherapy; breast; BODY RADIATION-THERAPY; QUALITY-OF-LIFE; BRAIN METASTASES; COMBINATION CHEMOTHERAPY; INTERNATIONAL SOCIETY; GERIATRIC ASSESSMENT; FOLLOW-UP; RADIOSURGERY; ONCOLOGY; SBRT;
D O I：
10.21037/tcr.2019.08.29
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
引用
收藏
页码：S197 / S206
页数：10
相关论文
共 50 条
  • [31] Radiotherapy Issues in Elderly Breast Cancer Patients
    Kunkler, Ian
    BREAST CARE, 2012, 7 (06) : 453 - 459
  • [32] Stereotactic Ablative Body Radiotherapy for Lung Cancer
    Franks, K. N.
    Jain, P.
    Snee, M. P.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 280 - 289
  • [33] Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Renal Cancer
    Hannan, Raquibul
    McLaughlin, Mark F.
    Pop, Laurentiu M.
    Pedrosa, Ivan
    Kapur, Payal
    Garant, Aurelie
    Ahn, Chul
    Christie, Alana
    Zhu, James
    Wangg, Tao
    Robles, Liliana
    Durakoglugil, Deniz
    Woldu, Solomon
    Margulis, Vitaly
    Gahan, Jeffrey
    Brugarolas, James
    Timmerman, Robert
    Cadeddu, Jeffrey
    EUROPEAN UROLOGY, 2023, 84 (03) : 275 - 286
  • [34] Superior outcomes of nodal metastases compared to visceral sites in oligometastatic colorectal cancer treated with stereotactic ablative radiotherapy
    O'Cathail, Sean M.
    Smith, Thomas
    Owens, Rob
    Zeniou, Anthi
    Tsang, Yatman
    Holyoake, Daniel L. P.
    Murray, Louise
    Harrison, Mark
    Hawkins, Maria A.
    RADIOTHERAPY AND ONCOLOGY, 2020, 151 : 280 - 286
  • [35] Advancing the Paradigm: Oligometastatic Disease and the Impact of Stereotactic Ablative Body Radiotherapy
    Shor, D.
    Khoo, V.
    Jayaprakash, K. T.
    CLINICAL ONCOLOGY, 2024, 36 (07) : 402 - 405
  • [36] Stereotactic radiotherapy for oligometastatic cancer: a prognostic model for survival
    de Vin, T.
    Engels, B.
    Gevaert, T.
    Storme, G.
    De Ridder, M.
    ANNALS OF ONCOLOGY, 2014, 25 (02) : 467 - 471
  • [37] The Role of Stereotactic Ablative Radiotherapy for Early-Stage and Oligometastatic Non-small Cell Lung Cancer: Evidence for Changing Paradigms
    Dahele, Max
    Senan, Suresh
    CANCER RESEARCH AND TREATMENT, 2011, 43 (02): : 75 - 82
  • [38] A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
    Al-Shafa, Faiez
    Arifin, Andrew J.
    Rodrigues, George B.
    Palma, David A.
    Louie, Alexander, V
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [39] Single-fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience
    Li, Michelle P.
    Kelly, Dianne
    Tan, Jennifer
    Siva, Shankar
    Kron, Tomas
    David, Steven
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (04) : 580 - 585
  • [40] Outcomes of High-Dose Stereotactic Ablative Radiotherapy to All/Multiple Sites for Oligometastatic Renal Cell Cancer Patients
    Ma, Ming-Wei
    Li, Hong-Zhen
    Gao, Xian-Shu
    Liu, Ming-Zhu
    Yin, Huan
    Yang, Kai-Wei
    Chen, Jia-Yan
    Ren, Xue-Ying
    Wang, Dian
    CURRENT ONCOLOGY, 2022, 29 (10) : 7832 - 7841
12345